The "Viral Vector and Plasmid DNA Manufacturing Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2019-2027" report has been added to ResearchAndMarkets.com's offering.
Viral Vector & Plasmid DNA Manufacturing Market: Overview
This report analyzes the current and future scenario of the global viral vector & plasmid DNA manufacturing market for the period 2019 to 2027. Increase in prevalence and incidence rates of cancer, genetic disorders and infectious diseases, high unmet needs in patients with rare disorders, and raised acceptance for comparatively newer treatment options in developing countries are likely to be major drivers of the global viral vector & plasmid DNA manufacturing market during the forecast period.
The viral vector & plasmid DNA manufacturing market report comprises an elaborate executive summary, including a snapshot that provides information on various segments of the market. It also provides information and data analysis of the global market with respect to segments based on type, application, disease, end-user, and region. A detailed qualitative analysis of drivers, restraints, and opportunities of the market has been provided in the market overview section. Additionally, the section comprises competitive matrix and profiles of key market players, along with business overview, to project the competitive landscape of the market. The section also provides market attractiveness analysis based on region and market share analysis in terms of key players, thereby presenting a thorough analysis of the overall competitive scenario in the viral vector & plasmid DNA manufacturing market.
Key Topics Covered:
1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Viral Vector & Plasmid DNA Manufacturing Market
4. Market Overview
4.1. Introduction
4.2. Overview
4.3. Market Dynamics
4.4. Global Viral Vector & Plasmid DNA Manufacturing Market Analysis and Forecast, 2017-2027
4.5. Porter's Five Force Analysis
5. Market Outlook
5.1. Top 3 players operating in the market space
5.2. Key Mergers & Acquisitions
5.2. List of Manufacturer by Location of Manufacturing Facility and Type of Vector Production
6. Global Viral Vector & Plasmid DNA Manufacturing Market Analysis and Forecast, by Type
6.1. Introduction & Definition
6.2. Key Findings/Developments
6.3. Global Viral Vector & Plasmid DNA Manufacturing Market Value Forecast, by Type, 2017-2027
6.4. Global Viral Vector & Plasmid DNA Manufacturing Market Attractiveness, by Type
7. Global Viral Vector & Plasmid DNA Manufacturing Market Analysis and Forecast, by Application
7.1. Introduction & Definition
7.2. Key Findings/Developments
7.3. Global Viral Vector & Plasmid DNA Manufacturing Market Value Forecast, by Application, 2017-2027
7.3.1. Gene Therapy
7.3.2. Vaccinology
7.3.3. Others
7.4. Global Viral Vector & Plasmid DNA Manufacturing Market Attractiveness, by Application
8. Global Viral Vector & Plasmid DNA Manufacturing Market Analysis and Forecast, by Disease
8.1. Introduction & Definition
8.2. Key Findings/Developments
8.3. Global Viral Vector & Plasmid DNA Manufacturing Market Value Forecast, by Disease, 2017-2027
8.4. Global Viral Vector & Plasmid DNA Manufacturing Market Attractiveness, by Disease
9. Global Viral Vector & Plasmid DNA Manufacturing Market Analysis and Forecast, by End-user
9.1. Introduction & Definition
9.2. Key Findings/Developments
9.3. Global Viral Vector & Plasmid DNA Manufacturing Market Value Forecast, by End-user, 2017-2027
9.4. Global Viral Vector & Plasmid DNA Manufacturing Market Attractiveness, by End-user
10. Global Viral Vector & Plasmid DNA Manufacturing Market Analysis and Forecast, by Region
10.1. Key Findings
10.2. Global Viral Vector & Plasmid DNA Manufacturing Market Value Forecast, by Region
10.3. Global Viral Vector & Plasmid DNA Manufacturing Market Attractiveness, by Country/Region
11. North America Viral Vector & Plasmid DNA Manufacturing Market Analysis and Forecast
11.1. Introduction
11.2. North America Viral Vector & Plasmid DNA Manufacturing Market Value Forecast, by Type, 2017-2027
11.3. North America Viral Vector & Plasmid DNA Manufacturing Market Value Forecast, by Application, 2017-2027
11.4. North America Viral Vector & Plasmid DNA Manufacturing Market Value Forecast, by Disease, 2017-2027
11.5. North America Viral Vector & Plasmid DNA Manufacturing Market Value Forecast, by End-user, 2017-2027
11.6. North America Viral Vector & Plasmid DNA Manufacturing Market Value Forecast, by Country, 2017-2027
11.7. North America Viral Vector & Plasmid DNA Manufacturing Market Attractiveness Analysis
12. Europe Viral Vector & Plasmid DNA Manufacturing Market Analysis and Forecast
13. Asia Pacific Viral Vector & Plasmid DNA Manufacturing Market Analysis and Forecast
14. Latin America Viral Vector & Plasmid DNA Manufacturing Market Analysis and Forecast
15. Middle East & Africa Viral Vector & Plasmid DNA Manufacturing Market Analysis and Forecast
16. Competition Landscape
16.1. Market Player - Competition Matrix (by Tier and Size of companies)
16.2. Company Profiles
16.2.1. Lonza
16.2.2. Catapult
16.2.3. uniQure N.V.
16.2.4. FUJIFILM Diosynth Biotechnologies
16.2.5. Kaneka Eurogentec S.A.
16.2.6. Oxford Biomedica
16.2.7. Spark Therapeutics, Inc.
16.2.8. Cobrabiologics
16.2.9. Merck kGA
For more information about this report visit https://www.researchandmarkets.com/r/b9ikho
View source version on businesswire.com: https://www.businesswire.com/news/home/20191212005705/en/
Contacts:
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
